1665-1146

1665-1146

S1665-11462023000300153

10.24875/bmhim.23000123

Mexico

Mexico

00 06 2023

00 06 2023

80 3 153 164

1

2002

2

2014

3

2022

4

2018 360

k821

5

2018 73

6

2016 27

216-25

7

2017 42

375-83

8

2022 23

1-25

9

2016 5

10

2021 9

138

11

2019 133

2159-67

12

2018 8

49

13

2019 11

521

14

2014 8

441

15

2021 10

2245

16

2016 2

747-57

17

2020 10

375-85

18

2019 10

2965

19

2020 86

102019

20

2015 15

347-60

21

2019 94

S3-9

22

2017 97

123-32

23

2018 2018

8653489

24

2019 37

9-16

25

2019 8

55

26

1975 256

495-7

27

1986 13

165-79

28

2020 38

25-34

29

2022 10

856049

30

2021 16

31

2020 11

1927

32

2017 25

1611-22

33

2012 526

99-106

34

2022 27

2151-69

35

2020 2020

3038564

36

2019 26

365-80

37

2019 41

335-46

38

2020 12

38

39

2020 9

34

40

2000 124

921-3

41

2018 8

1751

42

2019 7

43

2019 35

150927

44

2018 2

1-2

45

2018 11

187-8

46

2016 9

5-11

47

2019 37

1188-99

48

2014 1060

123-37

49

2019 27

37-51

50

2021 22

4774

51

2022 13

1841

52

2015 63

101-8

53

2009 1

326-31

54

2021 81

4641-51

55

2021 39

56

2022 13

1463-70

57

Clinicaltrials.gov 2021

58

2019 37

125

59

2019 79

1355-61

60

2020 80

617-24

61

2020 10

594558

62

2022 12

730666

63

2021 149

222-32

64

2012 297

45-81

65

2009 68

482-3

66

2016 28

309-16

67

2016 129

2125-33

68

2017 34

2232-73

69

2019 7

105

70

2015 67

28-45

71

2022 6

409-31

72

2021 71

101733

73

2022 164

1-17

74

2021 10

75

Besponsa (Pfizer)

2019 42

141-2

76

2021 137

1582-90

77

2019 33

884-92

78

2019 185

1017-20

79

2015 62

1171-5

80

2009 27

15s

81

2004 64

8349-56

82

2019 5

236-42

83

2021 39

1119-28

84

2021 4

85

2021 4

86

Swiss Group of Clinical Cancer Research (SAKK)

2018 87

104-10

87

2015 47

2107-14

88

2009

89

2022 7

93

90

2023 15

2153410